SCHEMBL30942995

SCHEMBL30942995

CC1(C)CC(=O)N(OCc2ccccc2)C1=O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
TSHR P16473 1/20 0.41
DHFR P00374 3/20 0.40
ELANE P08246 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KCNA5 P22460 2/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31306898 0.84 ALDH1A1 (0.51) ALDH1A1TSHRDHFRELANEMEN1
Hydrochloric Acid SCHEMBL10567076 0.76 CHRM2 (0.46) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL1929687 0.74 ALOX12 (0.54) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL20997478 0.74 ALOX12 (0.54) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL10567177 0.74 SIGMAR1 (0.47) ALDH1A1TSHRMEN1KMT2ACYP1A2
Hydrochloric Acid SCHEMBL6606867 0.73 ALOX12 (0.53) ALDH1A1TSHRMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL10565198 0.73 SIGMAR1 (0.48) ALDH1A1TSHRMEN1KMT2ACYP1A2
SCHEMBL2257976 0.72 ELANE (0.61) ELANEMEN1KMT2ACYP1A2CYP2D6
SCHEMBL20983872 0.71 ALDH1A1 (0.54) ALDH1A1TSHRDHFRELANEMEN1
SCHEMBL9242285 0.71 ALDH1A1 (0.54) ALDH1A1TSHRDHFRELANEMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608810-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-09-03 EP disclosed
WO-2024091498-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-05-02 WO disclosed